UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metastatic patterns in adenocarcinoma

Cancer, 2006-04, Vol.106 (7), p.1624-1633

2006

Volltextzugriff (PDF)

Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

Journal of clinical oncology, 2008-09, Vol.26 (27), p.4442-4448

2008

Volltextzugriff (PDF)

Cancer of Unknown Primary Site

The New England journal of medicine, 2014-08, Vol.371 (8), p.757-765

2014

Volltextzugriff (PDF)

Carcinoma of unknown primary with a colon-cancer profile—changing paradigm and emerging definitions

The lancet oncology, 2008-06, Vol.9 (6), p.596-599

2008

Volltextzugriff (PDF)

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Clinical cancer research, 1999-11, Vol.5 (11), p.3403-3410

1999

Volltextzugriff (PDF)

Metabolite profile of Salix reticulata methanolic extract and its antiproliferative effect on immortalized human keratinocytes

Planta medica, 2015, Vol.81 (16)

2015

Volltextzugriff (PDF)

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-12, Vol.83 (24), p.1797-1805

1991

Volltextzugriff (PDF)

A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary

International journal of clinical oncology, 2013-04, Vol.18 (2), p.226-231

2013

Volltextzugriff (PDF)

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2094-2103

1995

Volltextzugriff (PDF)

Metabolite profile and antiproliferative effects in HaCaT cells of a Salix reticulata extract

Planta Medica International Open, 2017, Vol.4 (S 01)

2017

Volltextzugriff (PDF)

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Journal of clinical oncology, 1994-06, Vol.12 (6), p.1272-1280

1994

Volltextzugriff (PDF)

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1993-03, Vol.85 (5), p.384-388

1993

Volltextzugriff (PDF)

Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary

Clinical cancer research, 2011-06, Vol.17 (12), p.4063-4070

2011

Volltextzugriff (PDF)

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors

Annals of oncology, 1998-09, Vol.9 (9), p.1003-1008

1998

Volltextzugriff (PDF)

The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)

Cancer treatment reviews, 1993-10, Vol.19 (4), p.351-386

1993

Volltextzugriff (PDF)

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Journal of clinical oncology, 1991-03, Vol.9 (3), p.491-498

1991

Volltextzugriff (PDF)

Post-intervention TCD examination may be useful to predict outcome in acute ischemic stroke patients with successful intra-arterial intervention

Journal of the neurological sciences, 2013-11, Vol.334 (1), p.26-29

2013

Volltextzugriff (PDF)

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Journal of clinical oncology, 1997-05, Vol.15 (5), p.2056-2066

1997

Volltextzugriff (PDF)

Unknown primary tumors metastatic to liver

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2105-2112

1998

Volltextzugriff (PDF)

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

International journal of clinical oncology, 2014-06, Vol.19 (3), p.479-484

2014

Volltextzugriff (PDF)

Transcranial Doppler Detection of Microembolic Signals During Pulmonary Vein Antrum Isolation: Implications for Titration of Radiofrequency Energy

Journal of cardiovascular electrophysiology, 2006-05, Vol.17 (5), p.495-501

2006

Volltextzugriff (PDF)

Radiatively heated high voltage pyroelectric crystal pulser

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2014, Vol.735, p.379-381

2014

Volltextzugriff (PDF)

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

Journal of clinical oncology, 1996-01, Vol.14 (1), p.287-295

1996

Volltextzugriff (PDF)

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

Journal of clinical oncology, 1996-02, Vol.14 (2), p.503-513

1996

Volltextzugriff (PDF)

Carcinoma of unknown primary origin: on the cusp of a new era

The cancer journal (Sudbury, Mass.), 2010-01, Vol.16 (1), p.66-67

Raber, Martin N

2010

Volltextzugriff (PDF)

1 – 25 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(240)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(270)
Französisch
(20)
Deutsch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(4)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Metastatic patterns in adenocarcinoma

Molecular Profiling of Carcinoma of Unknown Primary and Correlation With Clinical Evaluation

Cancer of Unknown Primary Site

Carcinoma of unknown primary with a colon-cancer profile—changing paradigm and emerging definitions

Classification and Regression Tree Analysis of 1000 Consecutive Patients with Unknown Primary Carcinoma

Metabolite profile of Salix reticulata methanolic extract and its antiproliferative effect on immortalized human keratinocytes

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

A phase II study to evaluate the efficacy and toxicity of oxaliplatin in combination with gemcitabine in carcinoma of unknown primary

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin

Metabolite profile and antiproliferative effects in HaCaT cells of a Salix reticulata extract

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer

Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors

The taxoids: paclitaxel (Taxol®) and docetaxel (Taxotere®)

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

Post-intervention TCD examination may be useful to predict outcome in acute ischemic stroke patients with successful intra-arterial intervention

Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?

Unknown primary tumors metastatic to liver

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

Transcranial Doppler Detection of Microembolic Signals During Pulmonary Vein Antrum Isolation: Implications for Titration of Radiofrequency Energy

Radiatively heated high voltage pyroelectric crystal pulser

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

Carcinoma of unknown primary origin: on the cusp of a new era

Suchergebnisse filtern